We are live on ! Find out more
Rafferty Asset Management

Rafferty Asset Management Portfolio holdings

AUM $24.6B
1-Year Est. Return 47.06%
This Fund
S&P 500
This Quarter Est. Return
-3.33%
1 Year Est. Return
+47.06%
3 Year Est. Return
+108.18%
5 Year Est. Return
+135.84%
10 Year Est. Return
+427.13%
AUM
$9.4B
AUM Growth
-$1.47B
Cap. Flow
-$936M
Cap. Flow %
-9.97%
Top 10 Hldgs %
27.51%
Holding
1,295
New
171
Increased
621
Reduced
344
Closed
156

Top Buys

Rank Stock Value
1
TLT icon
iShares 20+ Year Treasury Bond ETF
TLT
+$109M
2
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$60M
3
QCOM icon
Qualcomm
QCOM
+$51.7M
4
TXN icon
Texas Instruments
TXN
+$40M
5
MSFT icon
Microsoft
MSFT
+$37.6M

Top Sells

Rank Stock Value
1
IVV icon
iShares Core S&P 500 ETF
IVV
+$1.72B
2
INTC icon
Intel
INTC
+$70.3M
3
KWEB icon
KraneShares CSI China Internet ETF
KWEB
+$60.1M
4
FXI icon
iShares China Large-Cap ETF
FXI
+$43.5M
5
IWD icon
iShares Russell 1000 Value ETF
IWD
+$21.8M

Sector Composition

Rank Sector Weight
1 Technology 37.79%
2 Financials 14.33%
3 Healthcare 10.38%
4 Energy 7.34%
5 Consumer Discretionary 3.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ENTA icon
401
Enanta Pharmaceuticals
ENTA
$371M
$3.31M 0.04%
63,722
+8,526
+15% +$498K
HUM icon
402
Humana
HUM
$43.8B
$3.28M 0.04%
6,769
+3,700
+121% +$1.8M
HII icon
403
Huntington Ingalls Industries
HII
$13.1B
$3.28M 0.03%
14,795
-508
-3% -$114K
VCEL icon
404
Vericel Corp
VCEL
$2.39B
$3.27M 0.03%
140,991
+40,664
+41% +$1.11M
MYGN icon
405
Myriad Genetics
MYGN
$291M
$3.27M 0.03%
171,284
+62,482
+57% +$1.43M
EWW icon
406
iShares MSCI Mexico ETF
EWW
$1.97B
$3.2M 0.03%
72,328
-59,164
-45% -$2.72M
ICPT
407
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$3.15M 0.03%
225,604
+72,411
+47% +$1.17M
LGND icon
408
Ligand Pharmaceuticals
LGND
$5.76B
$3.13M 0.03%
58,237
+13,327
+30% +$783K
COGT icon
409
Cogent Biosciences
COGT
$6.69B
$3.12M 0.03%
+209,376
New +$2.87M
EQIX icon
410
Equinix
EQIX
$100B
$3.1M 0.03%
5,455
+1,114
+26% +$728K
GL icon
411
Globe Life
GL
$14.4B
$3.1M 0.03%
31,116
+2,380
+8% +$239K
RGNX icon
412
Regenxbio
RGNX
$627M
$3.1M 0.03%
117,107
+38,914
+50% +$1.15M
T icon
413
AT&T
T
$162B
$3.07M 0.03%
+200,289
New +$3.64M
HPQ icon
414
HP
HPQ
$24.8B
$3.03M 0.03%
121,608
+439
+0.4% +$13.5K
PAYC icon
415
Paycom
PAYC
$7.94B
$2.97M 0.03%
9,012
+915
+11% +$315K
XNCR icon
416
Xencor
XNCR
$1.47B
$2.97M 0.03%
114,342
+45,323
+66% +$1.3M
BSX icon
417
Boston Scientific
BSX
$71.6B
$2.97M 0.03%
76,593
+41,908
+121% +$1.68M
KYNB
418
Kyntra Bio
KYNB
$27.9M
$2.96M 0.03%
9,113
+3,026
+50% +$975K
DE icon
419
Deere & Co
DE
$166B
$2.96M 0.03%
8,849
+7,436
+526% +$2.55M
GLW icon
420
Corning
GLW
$121B
$2.95M 0.03%
101,654
+13,785
+16% +$467K
AKAM icon
421
Akamai
AKAM
$16.8B
$2.95M 0.03%
36,678
+3,867
+12% +$352K
PTGX icon
422
Protagonist Therapeutics
PTGX
$8.69B
$2.92M 0.03%
346,935
+32,703
+10% +$309K
MYOV
423
DELISTED
Myovant Sciences Ltd.
MYOV
$2.91M 0.03%
162,253
+56,882
+54% +$908K
CTXS
424
DELISTED
Citrix Systems Inc
CTXS
$2.9M 0.03%
27,894
+1,284
+5% +$131K
DAWN
425
DELISTED
Day One Biopharmaceuticals
DAWN
$2.9M 0.03%
+144,634
New +$3.08M
15 16
17
18 19

Similar funds

CS
Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return
AF
Allworth Financial Folsom, California $24.7B AUM 15.55% 1-Year Est. Return
SC
Scotia Capital Toronto, Ontario, Canada $24.3B AUM 29.21% 1-Year Est. Return
Voloridge Investment Management
Voloridge Investment Management Jupiter, Florida $25B AUM 28.08% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
JG
Jain Global New York $24.2B AUM 34.82% 1-Year Est. Return
Pathstone Holdings
Pathstone Holdings Englewood, New Jersey $25.1B AUM 22.95% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return

Rafferty Asset Management's Q3 2022 Portfolio in Review

As of Q3 2022, Rafferty Asset Management held 1,295 positions worth $9.4B, down 14% from $10.9B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Rafferty Asset Management withdrew a net $936M in Q3 2022, closing 156 positions and reducing 344 holdings. Its most notable exit was iShares Russell 1000 Value ETF, an estimated $21.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 38% of assets, up from 34% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Rafferty Asset Management opened a new position in American Express worth $28M.

  • Rafferty Asset Management's largest Q3 2022 buy was American Express: 207,400 shares worth $28M.
  • Rafferty Asset Management added most to iShares 20+ Year Treasury Bond ETF in Q3 2022, an estimated $109M increase.
  • Rafferty Asset Management's biggest Q3 2022 reduction was iShares Core S&P 500 ETF, cutting an estimated $1.72B.
  • Rafferty Asset Management fully exited iShares Russell 1000 Value ETF in Q3 2022, selling an estimated $21.8M.
  • Rafferty Asset Management's ten largest holdings make up 28% of its $9.4B portfolio in Q3 2022.
  • Rafferty Asset Management opened 171 new positions and closed 156 in Q3 2022.
  • Rafferty Asset Management's portfolio value fell 14% quarter-over-quarter to $9.4B.

Based on Rafferty Asset Management's 13F filing for Q3 2022, filed 14 Nov 2022.